Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA yield is N/A as of 2026-10-06T16:02:35.792Z.
Calculation as of: 2026-10-06T16:02:35.792Z.
Quote observation: 2026-10-06T15:59:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6ca46cb2503432b4e6be7669feb94d1504c8cb286efa91150a37fa2824e87886
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EBITDA YIELD
N/A
Market Cap
$4.59M
EBITDA Yield
N/A
TTM Avg
5.28%
3Y Avg
5.28%
5Y Avg
5.28%
Market Cap
$3.91M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.01M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78M
EBITDA Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Farmmi, Inc. (FAMI) | $4.68M | N/A | N/A | N/A | N/A |
| AquaBounty Technologies, Inc. (AQB)vs › | $4.59M | N/A | 5.28% | 5.28% | 5.28% |
| Elite Education Group International Limited (EEIQ)vs › | $3.91M | N/A | N/A | N/A | N/A |
| Agroz Inc. Ordinary Shares (AGRZ)vs › | $3.63M | N/A | N/A | N/A | N/A |
| Nocera, Inc. (NCRA)vs › | $2.60M | N/A | 3.75% | 3.75% | 3.75% |
| Chanson International Holding (CHSN)vs › | $2.40M | N/A | N/A | N/A | N/A |
| Agape ATP Corporation (ATPC)vs › | $2.14M | N/A | 0.00% | 0.00% | 0.00% |
| Golden Sun Education Group Limited (GSUN)vs › | $2.01M | N/A | N/A | N/A | N/A |
| Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH)vs › | $1.78M | N/A | N/A | N/A | N/A |
| IP Strategy Holdings, Inc. (IPST)vs › | $1.67M | N/A | N/A | N/A | N/A |
EBITDA Yield = TTM EBITDA / Enterprise Value
EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute